Loading data
DOMHNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 123.1 m USD | 20.97 m USD | 2.04 m USD | — | — |
| Research and development expense | — | — | 3 k USD | 830 k USD | 559 k USD |
| Selling, general and administrative expense | — | — | — | 11.68 m USD | 7.73 m USD |
| Operating profit | -55.73 m USD | -8.7 m USD | -21.8 m USD | -14.35 m USD | -9.44 m USD |
| Profit before tax | -13.15 m USD | -14.7 m USD | — | — | — |
| Income tax expense | 7.32 m USD | — | — | — | — |
| Net income (reported basis) | -22.44 m USD | -14.7 m USD | -22.88 k USD | -22.11 k USD | -7.17 m USD |
| Net income attributable to common shareholders | — | — | -22.88 m USD | -26.22 m USD | — |
| Basic earnings per share | -1.57 USD/share | -2.38 USD/share | -4.38 USD/share | -4.91 USD/share | -1.48 USD/share |
| Diluted earnings per share | -1.57 USD/share | -2.38 USD/share | -4.38 USD/share | -4.91 USD/share | -1.48 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.